Evan G. Smith

In addition to providing day-to-day corporate advice to many companies, Evan has advised:

Life Sciences/Healthcare

• Baird Capital in venture capital investments
• Boston Scientific in strategic investments in private companies
• Cytrellis Biosystems in venture capital financings
• DigitalOptometrics in strategic and growth financings
• Fractyl Laboratories in venture capital financings
• IntelyCare in venture capital financings
• Immuneering Corporation in its:
  • Venture capital financings
  • Combination with Teva Pharmaceuticals
  • Initial public offering
  • Periodic reports and public filings
• Kate Farms Inc. in growth financings
• Laminar, Inc. in angel and venture capital financings
• T2 Biosystems in its:
  • Initial public offering
  • Periodic reports and public filings
  • Takedown offerings
• Topera in its merger with Abbott Laboratories

Technology/Other

• A123 Systems in its merger with Wanxiang America and Navitas Systems
• A Cloud Guru in its:
  • Venture capital financings
  • Acquisition of Linux Academy
  • Sale to Pluralsight
• Ava Labs in corporate matters and token offerings
• Cartera Commerce in its merger with Ebates (Rakuten)
• Copiun in its:
  • Venture capital financings
  • Merger with Good Technology
• Cherre Inc. in early stage and growth financings
• Drizly in its formation and:
  • Venture capital financings
  • Sale to Uber Technologies for US$1.1 billion
• Education.com in its sale to IXL Learning
• The underwriters in the initial public offering of EverQuote
• The Farmer’s Dog in venture capital financings 
• Gaia Design in venture capital financings
• Ipswitch in its merger with Progress
• IXL Learning in its
  • acquisition of Rosetta Stone Languages
  • acquisition of Wyzant
• Micronetics in its merger with Mercury Computer Systems
• Network Engines in its merger with UNICOM Systems
• RealBlocks in early-stage and venture capital financings
• Revelops (Logentries) in its merger with Rapid7
• Synack in venture capital financings
• Twitch Interactive, Inc. in its US$970 million merger with a multi-national technology company
• TravelPerk in early-stage and venture capital financings